Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer

NCT00636883 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER_GOV

Sponsor class

Stopped slow accrual rate

Conditions

Pancreatic Cancer

Interventions

DRUG: Gemcitabine

Sponsor

National Guard Health Affairs